Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Elena D. Danilenko"'
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 99, Iss 6, Pp 661-668 (2023)
Background. The most effective way to prevent infectious diseases is vaccination. Adjuvants contribute to the optimization of the immune response of vaccines. Double-stranded ribonucleic acids (dsRNAs) from natural sources are promising, but insuffic
Externí odkaz:
https://doaj.org/article/e4e7bb6ee8714b21966061bcb2b424a7
Autor:
Svetlana S. Kirikovich, Evgeniy V. Levites, Anastasia S. Proskurina, Genrikh S. Ritter, Sergey E. Peltek, Asya R. Vasilieva, Vera S. Ruzanova, Evgeniya V. Dolgova, Sofya G. Oshihmina, Alexandr V. Sysoev, Danil I. Koleno, Elena D. Danilenko, Oleg S. Taranov, Alexandr A. Ostanin, Elena R. Chernykh, Nikolay A. Kolchanov, Sergey S. Bogachev
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 24, p 17396 (2023)
Group-specific component macrophage-activating factor (GcMAF) is the vitamin D3-binding protein (DBP) deglycosylated at Thr420. The protein is believed to exhibit a wide range of therapeutic properties associated with the activation of macrophagal im
Externí odkaz:
https://doaj.org/article/b4dd9f9c5d784e10a29bd25d8b630443
Autor:
Alexander B. Ryzhikov, Evgeny A. Ryzhikov, Marina P. Bogryantseva, Svetlana V. Usova, Elena A. Nechaeva, Elena D. Danilenko, Stepan A. Pyankov, Andrey S. Gudymo, Anastasiya A. Moiseeva, Galina S. Onkhonova, Oleg V. Pyankov, Ekaterina S. Sleptsova, Nikita V. Lomakin, Veronika S. Vasilyeva, Mikhail V. Tulikov, Vitaly G. Gusarov, Andrey A. Pulin, Maria A. Balalaeva, Svetlana B. Erofeeva, Stanislav A. Terpigorev, Olga A. Rychkova, Ivan M. Petrov, Viktoriia Y. Delian, Vladimir V. Rafalskiy, Sergey V. Tyranovets, Elena V. Gavrilova, Rinat A. Maksyutov
Publikováno v:
Vaccines, Vol 11, Iss 5, p 998 (2023)
The State Research Center of Virology and Biotechnology “VECTOR” of the Federal Service for the Oversight of Consumer Protection and Welfare (Rospotrebnadzor) has developed the peptide-based EpiVacCorona vaccine, which is the first synthetic pept
Externí odkaz:
https://doaj.org/article/200e423720e04b339bd6ba8dcab07260
Autor:
Ekaterina A. Volosnikova, Iuliia A. Merkuleva, Tatiana I. Esina, Dmitry N. Shcherbakov, Mariya B. Borgoyakova, Anastasiya A. Isaeva, Valentina S. Nesmeyanova, Natalia V. Volkova, Svetlana V. Belenkaya, Anna V. Zaykovskaya, Oleg V. Pyankov, Ekaterina V. Starostina, Alexey M. Zadorozhny, Boris N. Zaitsev, Larisa I. Karpenko, Alexander A. Ilyichev, Elena D. Danilenko
Publikováno v:
Vaccines, Vol 11, Iss 4, p 808 (2023)
Despite the rapid development and approval of several COVID vaccines based on the full-length spike protein, there is a need for safe, potent, and high-volume vaccines. Considering the predominance of the production of neutralizing antibodies targeti
Externí odkaz:
https://doaj.org/article/f1e47c9a247e478f964607cf1e5745a2
Autor:
Larisa N. Shishkina, Oleg Yu. Mazurkov, Nikolai I. Bormotov, Maksim O. Skarnovich, Olga A. Serova, Natalia A. Mazurkova, Maria A. Skarnovich, Alexander A. Chernonosov, Boris A. Selivanov, Alexey Ya. Tikhonov, Svetlana G. Gamaley, Galina G. Shimina, Galina M. Sysoyeva, Oleg S. Taranov, Elena D. Danilenko, Alexander P. Agafonov, Rinat A. Maksyutov
Publikováno v:
Viruses, Vol 15, Iss 1, p 205 (2023)
Background: Since most of the modern human population has no anti-smallpox immunity, it is extremely important to develop and implement effective drugs for the treatment of smallpox and other orthopoxvirus infections. The objective of this study is t
Externí odkaz:
https://doaj.org/article/692f7e36a073467dab49b1dc7acb682f
Autor:
Mariya B. Borgoyakova, Larisa I. Karpenko, Andrey P. Rudometov, Ekaterina A. Volosnikova, Iuliia A. Merkuleva, Ekaterina V. Starostina, Alexey M. Zadorozhny, Anastasiya A. Isaeva, Valentina S. Nesmeyanova, Daniil V. Shanshin, Konstantin O. Baranov, Natalya V. Volkova, Boris N. Zaitsev, Lyubov A. Orlova, Anna V. Zaykovskaya, Oleg V. Pyankov, Elena D. Danilenko, Sergei I. Bazhan, Dmitry N. Shcherbakov, Alexander V. Taranin, Alexander A. Ilyichev
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 4, p 2188 (2022)
Despite the fact that a range of vaccines against COVID-19 have already been created and are used for mass vaccination, the development of effective, safe, technological, and affordable vaccines continues. We have designed a vaccine that combines the
Externí odkaz:
https://doaj.org/article/4d510ffb1ac04a2aa2a3264a0aa2c237
Autor:
Larisa I, Karpenko, Alexey V, Danilenko, Sergei I, Bazhan, Elena D, Danilenko, Galina M, Sysoeva, Olga N, Kaplina, Olga Y, Volkova, Svetlana F, Oreshkova, Alexander A, Ilyichev
Publikováno v:
Microbial biotechnology
Summary This study is focusing on elucidation of the capacity of attenuated Salmonella enteritidis E23 (cya, crp) to serve as a vehicle for the rectal delivery of the DNA vaccine. Earlier for creation HIV‐1 candidate DNA vaccine we have designed th
Autor:
Larisa I, Karpenko, Alexander A, Ilyichev, Alexey M, Eroshkin, Leonid R, Lebedev, Roman V, Uzhachenko, Nadezhda A, Nekrasova, Olga A, Plyasunova, Pavel A, Belavin, Sergei V, Seregin, Nadezhda K, Danilyuk, Boris N, Zaitsev, Elena D, Danilenko, Valentina I, Masycheva, Sergei I, Bazhan
Publikováno v:
Vaccine. 25(21)
We have previously described designing of polyepitope immunogens TBI and TCI, to stimulate the humoral and cellular immune responses to HIV-1. Here, immunogens TBI and TCI were used to create new vaccine construct named CombiHIVvac (Combined HIV-1 va